NERLYNX® (NERATINIB) TABLETS: THE NEXT STEP IN EARLY-STAGE HER2+ BREAST CANCER

NERLYNX® (NERATINIB) TABLETS:

THE NEXT STEP IN EARLY-STAGE HER2+ BREAST CANCER

PRESENTED BY:

VICTORIA POILLUCCI, ACNP-BC,MSN,RN DUKE CANCER INSTITUTE

CARY, NC

PLEASE REGISTER BY VISITING US ONLINE AT:

http://PUMAREG.TSGMEDED.COM Enter Event Code: 49683

New Jersey, Minnesota, Vermont, the Department of Defense, and the Department of Veterans Affairs have restrictions on receiving in-kind benefits (e.g., meals, paid parking) at company-sponsored events.

For all attendees, please be advised that information such as your name and the value and purpose of any educational item, meal, or other items of value you receive may be publicly disclosed. You are accountable for understanding such restrictions and complying with them. If you are licensed in or affiliated with any of these states or federal agencies, Puma Biotechnology policies may restrict you from consuming any portion of the Puma Biotechnology-sponsored meal at this program or from receiving any other in-kind benefit from Puma Biotechnology (e.g., paid parking) in connection with the program.

This program is sponsored by Puma Biotechnology, Inc.

This is not an independent educational program, and no CME credits will be provided.